Cargando…
Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489293/ https://www.ncbi.nlm.nih.gov/pubmed/34619233 http://dx.doi.org/10.1016/j.kint.2021.09.015 |
| _version_ | 1784578322623102976 |
|---|---|
| author | Stervbo, Ulrik Blazquez-Navarro, Arturo Blanco, Elena Vidal Safi, Lema Meister, Toni L. Paniskaki, Krystallenia Stockhausen, Mara Marheinecke, Corinna Zimmer, Gert Wellenkötter, Jacqueline Giglio, Tina Arora, Prerna Pöhlmann, Stefan Hoffmann, Markus Seibert, Felix S. Pfaender, Stephanie Roch, Toralf Westhoff, Timm H. Cinkilic, Okan Babel, Nina |
| author_facet | Stervbo, Ulrik Blazquez-Navarro, Arturo Blanco, Elena Vidal Safi, Lema Meister, Toni L. Paniskaki, Krystallenia Stockhausen, Mara Marheinecke, Corinna Zimmer, Gert Wellenkötter, Jacqueline Giglio, Tina Arora, Prerna Pöhlmann, Stefan Hoffmann, Markus Seibert, Felix S. Pfaender, Stephanie Roch, Toralf Westhoff, Timm H. Cinkilic, Okan Babel, Nina |
| author_sort | Stervbo, Ulrik |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8489293 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84892932021-10-04 Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease Stervbo, Ulrik Blazquez-Navarro, Arturo Blanco, Elena Vidal Safi, Lema Meister, Toni L. Paniskaki, Krystallenia Stockhausen, Mara Marheinecke, Corinna Zimmer, Gert Wellenkötter, Jacqueline Giglio, Tina Arora, Prerna Pöhlmann, Stefan Hoffmann, Markus Seibert, Felix S. Pfaender, Stephanie Roch, Toralf Westhoff, Timm H. Cinkilic, Okan Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-12 2021-10-04 /pmc/articles/PMC8489293/ /pubmed/34619233 http://dx.doi.org/10.1016/j.kint.2021.09.015 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Stervbo, Ulrik Blazquez-Navarro, Arturo Blanco, Elena Vidal Safi, Lema Meister, Toni L. Paniskaki, Krystallenia Stockhausen, Mara Marheinecke, Corinna Zimmer, Gert Wellenkötter, Jacqueline Giglio, Tina Arora, Prerna Pöhlmann, Stefan Hoffmann, Markus Seibert, Felix S. Pfaender, Stephanie Roch, Toralf Westhoff, Timm H. Cinkilic, Okan Babel, Nina Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title | Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title_full | Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title_fullStr | Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title_full_unstemmed | Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title_short | Improved cellular and humoral immunity upon a second BNT162b2 and mRNA-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| title_sort | improved cellular and humoral immunity upon a second bnt162b2 and mrna-1273 boost in prime-boost vaccination no/low responders with end-stage renal disease |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489293/ https://www.ncbi.nlm.nih.gov/pubmed/34619233 http://dx.doi.org/10.1016/j.kint.2021.09.015 |
| work_keys_str_mv | AT stervboulrik improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT blazqueznavarroarturo improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT blancoelenavidal improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT safilema improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT meistertonil improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT paniskakikrystallenia improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT stockhausenmara improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT marheineckecorinna improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT zimmergert improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT wellenkotterjacqueline improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT gigliotina improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT aroraprerna improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT pohlmannstefan improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT hoffmannmarkus improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT seibertfelixs improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT pfaenderstephanie improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT rochtoralf improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT westhofftimmh improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT cinkilicokan improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease AT babelnina improvedcellularandhumoralimmunityuponasecondbnt162b2andmrna1273boostinprimeboostvaccinationnolowresponderswithendstagerenaldisease |